133 related articles for article (PubMed ID: 22496614)
1. Aberrant expression of N-methylpurine-DNA glycosylase influences patient survival in malignant gliomas.
Liu C; Tu Y; Yuan J; Mao X; He S; Wang L; Fu G; Zong J; Zhang Y
J Biomed Biotechnol; 2012; 2012():760679. PubMed ID: 22496614
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic reg IV is a novel prognostic marker for glioma patient survival.
Wang Q; Deng J; Yuan J; Wang L; Zhao Z; He S; Zhang Y; Tu Y
Diagn Pathol; 2012 Jun; 7():69. PubMed ID: 22713481
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of FAT10 is correlated with progression and prognosis of human glioma.
Yuan J; Tu Y; Mao X; He S; Wang L; Fu G; Zong J; Zhang Y
Pathol Oncol Res; 2012 Oct; 18(4):833-9. PubMed ID: 22402871
[TBL] [Abstract][Full Text] [Related]
4. N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide.
Tang JB; Svilar D; Trivedi RN; Wang XH; Goellner EM; Moore B; Hamilton RL; Banze LA; Brown AR; Sobol RW
Neuro Oncol; 2011 May; 13(5):471-86. PubMed ID: 21377995
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic correlation between the expression of the DNA repair enzyme N-methylpurine DNA glycosylase and esophageal adenocarcinoma onset: a retrospective pilot study.
Zaïr ZM; Johnson GE; Griffiths AP; Jenkins GJ
Dis Esophagus; 2013 Aug; 26(6):644-50. PubMed ID: 23137018
[TBL] [Abstract][Full Text] [Related]
6. Expression of the DNA repair enzyme, N-methylpurine-DNA glycosylase (MPG) in astrocytic tumors.
Kim NK; Ahn JY; Song J; Kim JK; Han JH; An HJ; Chung HM; Joo JY; Choi JU; Lee KS; Roy R; Oh D
Anticancer Res; 2003; 23(2B):1417-23. PubMed ID: 12820404
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of midkine and pleiotrophin predicts poor survival in human glioma.
Ma J; Lang B; Wang X; Wang L; Dong Y; Hu H
J Clin Neurosci; 2014 Nov; 21(11):1885-90. PubMed ID: 25001988
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients.
Sun B; Chu D; Li W; Chu X; Li Y; Wei D; Li H
J Neurooncol; 2009 Sep; 94(2):213-9. PubMed ID: 19337694
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of SMAD4 in gliomas correlates with progression and survival of patients.
He SM; Zhao ZW; Wang Y; Zhao JP; Wang L; Hou F; Gao GD
J Exp Clin Cancer Res; 2011 Jul; 30(1):70. PubMed ID: 21791112
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma.
Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Gao G; Zhang Y
J Clin Neurosci; 2013 Jul; 20(7):958-63. PubMed ID: 23707602
[TBL] [Abstract][Full Text] [Related]
12. RIZ1: a potential tumor suppressor in glioma.
Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y
BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of NIMA-related kinase 2 is associated with poor prognoses in malignant glioma.
Liu H; Liu B; Hou X; Pang B; Guo P; Jiang W; Ding Q; Zhang R; Xin T; Guo H; Xu S; Pang Q
J Neurooncol; 2017 May; 132(3):409-417. PubMed ID: 28321704
[TBL] [Abstract][Full Text] [Related]
14. High level of Sema3C is associated with glioma malignancy.
Vaitkienė P; Skiriutė D; Steponaitis G; Skauminas K; Tamašauskas A; Kazlauskas A
Diagn Pathol; 2015 Jun; 10():58. PubMed ID: 26032848
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-1 expression in human glioma is correlated with advanced tumor progression and poor prognosis.
Xu Y; Yuan J; Zhang Z; Lin L; Xu S
Mol Biol Rep; 2012 Sep; 39(9):8979-85. PubMed ID: 22714920
[TBL] [Abstract][Full Text] [Related]
16. Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas.
Liu N; Wang Z; Cheng Y; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y
Hum Pathol; 2016 Dec; 58():105-112. PubMed ID: 27574811
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of MMP-14 and MMP-19 predicts poor survival in human glioma.
Wang L; Yuan J; Tu Y; Mao X; He S; Fu G; Zong J; Zhang Y
Clin Transl Oncol; 2013 Feb; 15(2):139-45. PubMed ID: 22855183
[TBL] [Abstract][Full Text] [Related]
18. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma.
He S; Deng J; Li G; Wang B; Cao Y; Tu Y
Jpn J Clin Oncol; 2012 Mar; 42(3):196-201. PubMed ID: 22217575
[TBL] [Abstract][Full Text] [Related]
20. The Potential Prognostic Value of MicroRNA-429 for Human Gliomas.
Sun X; Li Z; Chen Y
Ann Clin Lab Sci; 2016; 46(1):44-8. PubMed ID: 26927341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]